中西医综合治疗气虚证缺血性中风的疗效评价研究

发布时间：2018-07-01 08:56

本文选题：缺血性中风恢复期 + 中西医综合疗法　；参考：《辽宁中医杂志》2015年02期

【摘要】：目的:观察缺血性中风恢复期痰瘀互结兼气虚证中西医综合治疗方案,借以提高中西医结合综合治疗方案干预本病证的疗效。方法:采用多中心、区组随机、盲法、平行对照试验,运用描述性统计方法,t检验,重复测量资料方差分析等统计方法对数据进行统计分析。结果:240例患者参与随机分配,1例随机号错误,试验组3例时间超窗,1例肌酐超标被排除出全分析数据集,符合方案数据集116例。对照组4例时间超窗,1例失访,1例不良事件排除出全分析数据集,符合方案数据集人数113例。试验组与对照组比较,0周一般资料具有可比性,量表基线相平,第4周缺血性中风恢复期痰瘀互结兼气虚证证候积分表总分试验组xs恕纒为35.40±6.00,对照组xs恕纒为37.56±7.23,差异有统计学意义P(0.015)0.05。结论:中西医结合综合治疗方案能有效地改善缺血性中风病恢复期痰瘀互结兼气虚证患者的中医临床症状。
[Abstract]:Objective: to observe the comprehensive treatment scheme of phlegm and blood stasis and qi deficiency syndrome in the recovery period of ischemic apoplexy, so as to improve the curative effect of integrated traditional Chinese and western medicine therapy. Methods: the data were analyzed by multi-center, block random, blind, parallel controlled trial, descriptive statistical method and variance analysis of repeated measurement data. Results one case of random number error was randomly assigned to 240 patients. In the test group, 3 cases of time super window and 1 case of creatinine exceeding standard were excluded from the total analysis data set, 116 cases were in accordance with the scheme data set. In the control group, 4 cases of time overwindow and 1 case of missing visit and 1 case of adverse events were excluded from the total analysis data set, and 113 cases were in accordance with the scheme data set. Compared with the control group, the general data of 0 weeks in the trial group were comparable, and the baseline of the scale was even. In the 4th week, the total score of phlegm and blood stasis and qi deficiency syndrome in the experimental group was 35.40 卤6.00, while that in the control group was 37.56 卤7.23.The difference was statistically significant (P _ (0.015) 0.05). Conclusion: the integrated treatment of TCM and western medicine can effectively improve the clinical symptoms of the patients with syndromes of phlegm and blood stasis and deficiency of qi in the convalescent period of ischemic apoplexy.
【作者单位】：辽宁中医药大学;
【基金】：重大新药创制科技专项资助项目(2009zx09502-029)
【分类号】：R743.3

【参考文献】